Latest news
AXSM: Q2 revenue rose 46% to $218M, driven by AUVELITY's new indication and robust portfolio growth - TradingViewTradingView · Mon, 10 Aug 2026 13:51:33 GMTAxsome Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Mon, 10 Aug 2026 13:30:46 GMTAxsome (AXSM) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 13:30:04 GMTAXSM: Q2 revenue rose 46% year-over-year, driven by AUVELITY's growth and new Alzheimer's indication - TradingViewTradingView · Mon, 10 Aug 2026 13:21:06 GMTAxsome Therapeutics Q2 Earnings Call Highlights - MarketBeatMarketBeat · Mon, 10 Aug 2026 13:19:46 GMTAxsome Therapeutics (AXSM) Reports Q2 Loss, Misses Revenue Estimates - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 12:30:02 GMTAxsome Therapeutics Q2 Loss Widens, Revenue Increases - MoomooMoomoo · Mon, 10 Aug 2026 11:56:40 GMTAxsome Therapeutics (NASDAQ:AXSM) Issues Quarterly Earnings Results - MarketBeatMarketBeat · Mon, 10 Aug 2026 11:41:44 GMT